Upregulation of pancreatic derived factor (FAM3B) expression in pancreatic β-cells by MCP-1 (CCL2)

被引:9
作者
Hou, Xinwei [1 ]
Wang, Oumei [1 ]
Li, Zongmeng [1 ]
Mou, Haiwei [1 ]
Chen, Juan [1 ]
Deng, Bo [1 ]
Qian, Lihua [1 ]
Liu, Xiaolong [2 ]
Le, Yingying [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Grad Sch, Key Lab Nutr & Metab, Shanghai, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
CCL2; Pancreatic derived factor; FAM3B; Pancreatic islet; beta-Cell; Signal transduction; MONOCYTE CHEMOATTRACTANT PROTEIN-1; FACTOR-KAPPA-B; FACTOR PANDER; ISLET TRANSPLANTATION; OBESE SUBJECTS; KINASE-C; IN-VITRO; ACTIVATION; GENE; GLUCOSE;
D O I
10.1016/j.mce.2011.05.039
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Pancreatic derived factor (PANDER, FAM3B) is a peptide mainly synthesized and secreted by pancreatic beta-cells. PANDER is proposed to be involved in regulation of beta-cell function under physiological conditions and impairment of beta-cell function under pathological conditions. MCP-1 (CCL2) is expressed by normal pancreatic islets and has been implicated in inflammation related pancreatic disorders. We examined the effect of MCP-1 on PANDER expression by using murine pancreatic beta-cell line MIN6 and pancreatic islets. We found that MCP-1 induced PANDER mRNA transcription and protein synthesis in MIN6 cells and islets. By using calcium chelator (EGTA); inhibitors for PKC (Go6976), MEK1/2 (PD98059) or c-Jun-N-terminal kinase (JNK) (SP600125); c-Jun dominant-negative construct; PANDER promoter luciferase constructs; and islets isolated from Fos knockout mice; we demonstrated that MCP-1 induced PANDER gene expression in beta-cells through Ca2+-ERK1/2-AP-1 and PKC-JNK-AP-1 signaling pathways. Our findings suggest a new link between the endocrine and immune systems and provide useful information for further investigating the physiological functions of PANDER and its involvement in inflammation-related pancreatic disorders. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:18 / 24
页数:7
相关论文
共 50 条
  • [31] Gene therapy with CCL2 (MCP-1) mutant protects CVB3-induced myocarditis by compromising Th1 polarization
    Yue, Yan
    Gui, Jun
    Xu, Wei
    Xiong, Sidong
    MOLECULAR IMMUNOLOGY, 2011, 48 (04) : 706 - 713
  • [32] Hexanic lipidosterolic extract of Serenoa repens inhibits the expression of two key inflammatory mediators, MCP-1/CCL2 and VCAM-1, in vitro
    Latil, Alain
    Libon, Christine
    Templier, Marie
    Junquero, Didier
    Lantoine-Adam, Frederique
    Thien Nguyen
    BJU INTERNATIONAL, 2012, 110 (6B) : E301 - E307
  • [33] Intracellular ATP Signaling Contributes to FAM3A-Induced PDX1 Upregulation in Pancreatic Beta Cells
    Yan, Han
    Chen, Zhenzhen
    Zhang, Haizeng
    Yang, Weili
    Liu, Xiangyang
    Meng, Yuhong
    Xiang, Rui
    Wu, Zhe
    Ye, Jingjing
    Chi, Yujing
    Yang, Jichun
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2022, 130 (08) : 498 - 508
  • [34] Synergistic induction of CCL2/MCP-1 expression driven by oncostatin M and IL-1 beta in human proximal tubular cells depends on STAT3 and p65 NF kappa B/RelA
    Sarkozi, Rita
    Corazza, Ulrike
    Osterkamp, Jan-Philipp
    Pirklbauer, Markus
    Mayer, Gert
    Schramek, Herbert
    PHYSIOLOGICAL REPORTS, 2015, 3 (02):
  • [35] Induction of CCL2 by siMAML1 through upregulation of TweakR in melanoma cells
    Kang, Shijun
    Yang, Chunlan
    Luo, Rongcheng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 372 (04) : 629 - 633
  • [36] Monocyte Chemotactic Protein-1 (MCP-1/CCL2) Is Associated With Prostatic Growth Dysregulation and Benign Prostatic Hyperplasia
    Fujita, Kazutoshi
    Ewing, Charles M.
    Getzenberg, Robert H.
    Parsons, J. Kellogg
    Isaacs, William B.
    Pavlovich, Christian P.
    PROSTATE, 2010, 70 (05) : 473 - 481
  • [37] Rgs2 Mediates Pro-Angiogenic Function of Myeloid Derived Suppressor Cells in the Tumor Microenvironment via Upregulation of MCP-1
    Boelte, Kimberly C.
    Gordy, Laura E.
    Joyce, Sebastian
    Thompson, Mary Ann
    Yang, Li
    Lin, P. Charles
    PLOS ONE, 2011, 6 (04):
  • [38] Targeting Galectin-1 in Carcinoma-Associated Fibroblasts Inhibits Oral Squamous Cell Carcinoma Metastasis by Downregulating MCP-1/CCL2 Expression
    Wu, Ming-Heng
    Hong, Hsiao-Chin
    Hong, Tse-Ming
    Chiang, Wei-Fan
    Jin, Ying-Tai
    Chen, Yuh-Ling
    CLINICAL CANCER RESEARCH, 2011, 17 (06) : 1306 - 1316
  • [39] MCP-1/CCL2 Mediated by Autocrine Loop of PDGF-BB Promotes Invasion of Lung Cancer Cell by Recruitment of Macrophages Via CCL2-CCR2 Axis
    Ding, Mei
    He, Shao-Jun
    Yang, Jiong
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2019, 39 (04) : 224 - 232
  • [40] Effect of Diallyl Trisulfide on TNF-α-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer Cells
    Kanga, Konan J. W.
    Mendonca, Patricia
    Soliman, Karam F. A.
    Ferguson, Dominique T.
    Darling-Reed, Selina F.
    ANTICANCER RESEARCH, 2021, 41 (12) : 5919 - 5933